Medline INC

Medline Inc. announced second quarter and first six months 2026 results, showing an 11.6% increase in net sales to $7.7 billion but a 58.3% decrease in net income to $139 million.

Medline Inc. announced the upcoming retirement of its Chief Operating Officer, Stephen L. Miller, effective August 30, 2026, due to health-related reasons.

Medline Inc. successfully concluded its 2026 Annual Meeting, with shareholders electing all 12 director nominees and ratifying executive compensation and auditor selection.

Medline Borrower LP and Medline Co-Issuer Inc. have issued $1.25 billion in 5.000% Senior Secured Notes due 2031 and $750 million in 5.250% Senior Secured Notes due 2033, refinancing existing debt.

Medline Inc. announced first quarter 2026 results, with net sales increasing 10.7% to $7.4 billion, while net income decreased 25.8% to $239 million, prompting a raise in full-year organic sales guidance.

Medline Inc. announced robust fourth quarter and full year 2025 net sales growth and the completion of its Initial Public Offering, despite a notable decrease in net income driven by higher costs.

Medline Inc. announced a 11.6% increase in net sales for the quarter ended June 27, 2026, driven by volume growth, though facing challenges from a warehouse fire and increased operating expenses.

Medline Inc. announced its first quarter 2026 financial results, showcasing a 10.7% increase in net sales to $7.4 billion, driven by volume growth, while navigating the impact of tariffs and increased operating expenses.

Medline Inc. reports strong net sales growth and strategic acquisitions in its 2025 Annual Report, navigating a dynamic healthcare landscape and post-IPO environment.

GIC Private Ltd and 2 others reported changes in beneficial ownership of Medline Inc. common stock on August 13, 2026.

GIC Private Ltd and 2 others reported changes in beneficial ownership of Medline Inc. common stock on August 7, 2026.

Executive Vice President William J. Abrams reported the withholding of 1,308 shares of Medline Inc. common stock to satisfy tax obligations related to restricted stock unit vesting.

Medline Inc. Chief Human Resources Officer Christopher P. Shryock reported a transaction involving Class A Common Stock, with shares withheld for tax liabilities.

Medline Inc. Chief Operating Officer Stephen L. Miller reported a disposition of Class A Common Stock to cover tax liabilities.

Alexander M. Liberman, Chief Legal Officer of Medline Inc., reported a transaction involving the sale of Class A Common Stock to cover tax liabilities.

Medline Inc. has announced its 2026 Annual Meeting of Stockholders, to be held virtually on June 11, 2026, with key proposals including director elections and executive compensation.

Medline Inc. has filed to register an additional 14.4 million shares of Class A common stock at $37.00 per share, signaling strong investor demand for its initial public offering.

Medline Inc. has filed a registration statement for the sale of 60 million shares of its Class A common stock by selling stockholders.

Medline Inc. selling stockholders are offering 75 million Class A common shares, with the company receiving no proceeds from the sale.

Several Hellman & Friedman affiliated entities have amended their Schedule 13G filing to report an aggregate beneficial ownership of 16.0% of Medline Inc.'s Class A common stock as of June 30, 2026.

Several Blackstone-affiliated entities have collectively reported beneficial ownership of approximately 16.5% of Medline Inc.'s Class A Common Stock as of June 30, 2026.

FMR LLC and Abigail P. Johnson have reported beneficial ownership of 5.5% of Medline Inc.'s Class A Common Stock as of June 30, 2026.

The Carlyle Group and its affiliates have filed a Schedule 13G reporting a 20.6% beneficial ownership stake in Medline Inc. Class A Common Stock.

Abu Dhabi Investment Authority and its subsidiary Platinum Falcon B 2018 RSC Limited have filed a Schedule 13G, reporting beneficial ownership of Medline Inc. Class A Common Stock.

Private equity firm Hellman & Friedman reports a significant 19.8% beneficial ownership in Medline Inc. following its recent initial public offering.